Lionel Ségard

Fundador en QUANTUM GENOMICS .

58 años

Finance

Consumer Services

Health Technology

Perfil

Lionel Ségard is the founder of Quantum Genomics SA, which was founded in 2005.
He is also the founder of INSERM Transfert Initiative SAS. Mr. Ségard's current job is Chairman at Eurobiobiz SAS since 1999 and Vice Chairman at Rugby Club Massy Essonne SA since 2013.
Mr. Ségard's former job was Chief Executive Officer at INSERM Transfert SA from 2000 to 2006.
He obtained his undergraduate degree from Université de Paris XI Paris Sud.

Cargos activos de Lionel Ségard

Empresas	Cargo	Inicio
QUANTUM GENOMICS	Fundador	23/12/2005
Rugby Club Massy Essonne SA Rugby Club Massy Essonne SA Movies/EntertainmentConsumer Services Operates sport club	Director/Miembro de la Junta	-
Eurobiobiz SAS Eurobiobiz SAS Pharmaceuticals: OtherHealth Technology Specializes in creating and developing biotechnology companies in Europe	Presidente	01/01/1999

Todos los cargos activos de Lionel Ségard

Antiguos cargos conocidos de Lionel Ségard.

Empresas	Cargo	Fin
INSERM Transfert SA INSERM Transfert SA Investment ManagersFinance ITSA is an active private equity investment manager focused exclusively on the French biomedical sector, particularly on areas related to INSERM's medical research effort. They favor projects in fields including therapeutic agents, medical devices, diagnostics, tools and technological platforms. The firm invests between EUR 100 and 300 thousand in pre-seed and seed financing. ITSA's investment criteria include sound science, a driven management team, strong IP, a realistic business model with a clearly defined market, and a competitive milestone-driven schedule. They seek to invest in ambitious projects addressing unmet medical needs and potentially leading to dominant market positions. The firm may act as a co-founder, generally sits on the board of their portfolio companies and actively participates in their strategic decisions.	Director Ejecutivo	-
INSERM Transfert Initiative SAS INSERM Transfert Initiative SAS Investment ManagersFinance Acts as Venture Capital Fund	Fundador	-

Ver el detalle de la experiencia de Lionel Ségard.

Formación de Lionel Ségard.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Lionel Ségard.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	6
INSERM Transfert SA INSERM Transfert SA Investment ManagersFinance ITSA is an active private equity investment manager focused exclusively on the French biomedical sector, particularly on areas related to INSERM's medical research effort. They favor projects in fields including therapeutic agents, medical devices, diagnostics, tools and technological platforms. The firm invests between EUR 100 and 300 thousand in pre-seed and seed financing. ITSA's investment criteria include sound science, a driven management team, strong IP, a realistic business model with a clearly defined market, and a competitive milestone-driven schedule. They seek to invest in ambitious projects addressing unmet medical needs and potentially leading to dominant market positions. The firm may act as a co-founder, generally sits on the board of their portfolio companies and actively participates in their strategic decisions.	Finance
Université de Paris XI Paris Sud Université de Paris XI Paris Sud Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Eurobiobiz SAS Eurobiobiz SAS Pharmaceuticals: OtherHealth Technology Specializes in creating and developing biotechnology companies in Europe	Health Technology
INSERM Transfert Initiative SAS INSERM Transfert Initiative SAS Investment ManagersFinance Acts as Venture Capital Fund	Finance
Rugby Club Massy Essonne SA Rugby Club Massy Essonne SA Movies/EntertainmentConsumer Services Operates sport club	Consumer Services
Quantum Genomics SA Quantum Genomics SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for cardiovascular diseases	Health Technology